These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 37705745)
21. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262 [TBL] [Abstract][Full Text] [Related]
22. TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system. Humbert L; Lebrun JJ Cell Signal; 2013 Feb; 25(2):490-500. PubMed ID: 23085456 [TBL] [Abstract][Full Text] [Related]
23. Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans. Iwaki T; Tanaka A; Miyawaki Y; Suzuki A; Kobayashi T; Takamatsu J; Matsushita T; Umemura K; Urano T; Kojima T; Terao T; Kanayama N J Thromb Haemost; 2011 Jun; 9(6):1200-6. PubMed ID: 21486382 [TBL] [Abstract][Full Text] [Related]
24. Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway. Liu L; Meng T; Zheng X; Liu Y; Hao R; Yan Y; Chen S; You H; Xing J; Dong Y Mol Cancer Ther; 2019 Dec; 18(12):2457-2468. PubMed ID: 31488699 [TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling. Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315 [TBL] [Abstract][Full Text] [Related]
26. microRNA-10b promotes the apoptosis of bovine ovarian granulosa cells by targeting plasminogen activator inhibitor-1. Guo L; Huang Q; Zhao J; Liu H; Lu W; Wang J Theriogenology; 2021 Dec; 176():206-216. PubMed ID: 34627051 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
28. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
29. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer. Su YH; Wu YZ; Ann DK; Chen JL; Kuo CY Cell Death Dis; 2023 Jan; 14(1):53. PubMed ID: 36681663 [TBL] [Abstract][Full Text] [Related]
30. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Xi X; Liu N; Wang Q; Chu Y; Yin Z; Ding Y; Lu Y Cell Death Dis; 2019 Oct; 10(10):757. PubMed ID: 31591377 [TBL] [Abstract][Full Text] [Related]
31. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728 [TBL] [Abstract][Full Text] [Related]
32. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Chen H; Peng H; Liu W; Sun Y; Su N; Tang W; Zhang X; Wang J; Cui L; Hu P; Liu S Surgery; 2015 Dec; 158(6):1704-13. PubMed ID: 26275833 [TBL] [Abstract][Full Text] [Related]
33. A novel function of plasminogen activator inhibitor-1 in modulation of the AKT pathway in wild-type and plasminogen activator inhibitor-1-deficient endothelial cells. Balsara RD; Castellino FJ; Ploplis VA J Biol Chem; 2006 Aug; 281(32):22527-36. PubMed ID: 16785241 [TBL] [Abstract][Full Text] [Related]
34. The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding. Kubala MH; DeClerck YA Cancer Metastasis Rev; 2019 Sep; 38(3):483-492. PubMed ID: 31734763 [TBL] [Abstract][Full Text] [Related]
35. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway. Zhang LY; Zhang YQ; Zeng YZ; Zhu JL; Chen H; Wei XL; Liu LJ Breast Cancer Res Treat; 2020 Jul; 182(1):21-33. PubMed ID: 32415497 [TBL] [Abstract][Full Text] [Related]
36. The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner. Li F; Zhao S; Guo T; Li J; Gu C Biomed Res Int; 2019; 2019():2585743. PubMed ID: 31119158 [TBL] [Abstract][Full Text] [Related]
37. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518 [TBL] [Abstract][Full Text] [Related]
38. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression. He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531 [TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells. Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190 [TBL] [Abstract][Full Text] [Related]
40. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer. Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]